MedTrace Logo

Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment

NCT01758263 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2013-01-01

No results posted yet for this study

Summary

This is a retrospective data analysis of patients with high blood pressure (hypertension) who took metoprolol for a minimum of 6 months who then switched to taking nebivolol for a minimum of 6 month to treat hypertension. These patients will be identified from a large medical claims database. This study tests the hypothesis (alternative, higher or lower) that average patient monthly health care administrative cost changes after switching from metoprolol to nebivolol.

Conditions

Interventions

DRUG

Metoprolol

Metoprolol, oral administration

DRUG

Nebivolol

Nebivolol, oral administration

Sponsors & Collaborators

  • Forest Laboratories

    lead INDUSTRY

Principal Investigators

  • Stephanie Chen, PhD · Forest Laboratories

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2012-12-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01758263 on ClinicalTrials.gov